Course Chairs

Roger J. Bedimo, MD, MS
University of Texas Southwestern Medical Center
Laura W. Cheever, MD, ScM
The Health Resources and Services Administration
Michael S. Saag, MD
University of Alabama at Birmingham


Jean Anderson, MD
The Johns Hopkins University
Connie L. Celum, MD, MPH
University of Washington
Francine Cournos, MD
Francine Cournos, MD
Columbia University
Ellen F. Eaton, MD
University of Alabama at Birmingham
Steven K. Grinspoon, MD
Harvard Medical School
Nadine Kaslow
Nadine J. Kaslow, PhD
Emory University
Richard Koup, MD
Vaccine Research Center, NIAID, NIH
David H. Spach, MD
University of Washington
Victor G. Valcour, MD, PhD
University of California San Francisco
Ronald D. Wilcox, MD
The Health Resources and Services Administration

December 3-5, 2023 Portland, Oregon


The Hilton Portland Downtown
921 SW Sixth Avenue
United States

Please note: the 2023 RWHAP CLINICAL CONFERENCE will be in-person only. There will not be a virtual component.

This activity is eligible for CME credits, ABIM MOC points, AAFP credits, nursing credits, and pharmacist credits.




The 2023 Ryan White HIV/AIDS Program (RWHAP) CLINICAL CONFERENCE will be held in-person in Portland, Oregon, from Sunday, December 3, to Tuesday, December 5. The RWHAP CLINICAL CONFERENCE will provide state-of-the-art updates on research, care, and treatment issues in the medical management of HIV infection for experienced HIV clinical decision makers.

The 2023 RWHAP CLINICAL CONFERENCE is planned with and supported by the HIV/AIDS Bureau, Health Resources and Services Administration of the US Department of Health and Human Services (HRSA) and is sponsored and organized by the International Antiviral Society-USA (IAS-USA). This conference is coordinated through the RWHAP AIDS Education and Training Centers (AETC) clinician training network. A mix of lectures, case-based interactive presentations, and small-group workshop breakout sessions will be held during the 3 days of the 2023 RWHAP CLINICAL CONFERENCE.

Who Should Attend

Attendance is limited to HIV physicians, nurse practitioners, and physician assistants in Ryan White HIV/AIDS Program (RWHAP)-funded clinics and programs (specifically for in part A, B, C, and D), who functions as medical director of their clinic. As we are not sure what the status of the COVID-19 pandemic will be in December, we are planning for distanced seating in the main meeting space. This will limit the number of attendees we can accommodate to ensure the health and safety of our attendees. The first 300 registrants will have access to seating in the main meeting room. The next 100 registrants will be in the overflow seating outside the main meeting room, but will still have access to breakout sessions and networking opportunities. At this point, given the limited attendance, there will be a limit on how many can attend from each institution or clinic.

The 2023 RWHAP CLINICAL CONFERENCE will offer limited number of registrations for RNs and PharmDs who are the primary clinical decision makers/medical directors in their RWHAP-funded clinics or programs.

There is no registration fee to attend.

Learning Objectives

The educational objectives for the 2023 RWHAP CLINICAL CONFERENCE are designed and developed based on the identified needs and knowledge gaps of the attendees.

On completion of the 2023 RWHAP CLINICAL CONFERENCE, participants will be able to:

  • Describe the new aspects to the Ryan White HIV/AIDS Program
  • Identify situations in which the choice of antiretroviral regimen should consider particular clinical circumstances, such as comorbid conditions, coinfections, pregnancy, and issues in older patients
  • Describe the most current data on currently available and investigational new antiretroviral drugs, formulations, and strategies
  • Initiate and monitor HIV prevention intervention strategies, including the use of long-acting injectable preexposure prophylaxis (PrEP), in individuals at risk for HIV infection
  • Describe the current epidemiology, clinical presentations, and management of the most common sexually transmitted infections (STIs) in adults with HIV infection and in special populations such as adolescents
  • Detect and address practitioner and staff burnout
  • Describe the current best practices of postnatal HIV care and prevention, including issues around breastfeeding
  • Implement key primary care practices
  • Describe the implications of bNAbs vaccines for an HIV vaccine
  • Detect and manage opioid use disorder in people with HIV
  • Provide gender-affirming care to people with HIV
  • Address health disparities in disparate populations

IAS-USA Accreditation Statement

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The IAS–USA designates this live activity for a maximum of 12.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


ABIM MOCSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 12.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

American Academy of Family Physicians Credits

These activities are eligible for AAFP credit, see final AAFP activity announcement for specific details.

Nursing Credits

These activities are eligible for ANCC credit, see final CNE activity announcement for specific details.

Pharmacy Credits

Accreditation Council for Pharmacy Education logo These activities are eligible for ACPE credit, see final CPE activity announcement for specific details.

Conference Funding

This conference is funded by the Health Resources and Services Administration (HRSA) of the US Department of Health and Human Services (HHS) under grant number U1OHA28686.